1. Arrese M, Cortés V, Barrera F, Nervi F. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship. Current opinion in gastroenterology. 2018;34(2):90-6. 2. Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future. Liver International. 2018;38:47-51. 3. Zhao N, Guo F-F, Xie K-Q, Zeng T. Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease. Cellular and Molecular Life Sciences. 2018;75(17):3143-57. 4. Amirkalali B, Poustchi H, Keyvani H, Khansari MR, Ajdarkosh H, Maadi M, et al. Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran. Iranian journal of public health. 2014;43(9):1275. 5. Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nature reviews Gastroenterology & hepatology. 2019;16(6):377-86. 6. Adam RAA. A Study of Non Alcoholic Fatty Liver Disease and its Associated Risk Factors in Sudanese using Computed Tomography: Sudan University of Science and Technology; 2019. 7. Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. The Journal of clinical investigation. 2020;130(3). 8. Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M, et al. Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology. 2020. 9. Soto-Angona Ó, Anmella G, Valdés-Florido MJ, De Uribe-Viloria N, Carvalho AF, Penninx BW, et al. Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches. BMC medicine. 2020;18(1):1-14. 10. De Almeida Jr HL, Sartori DS, Jorge VM, Rocha NM, de Castro LAS. Phytophotodermatitis: A Review of Its Clinical and Pathogenic Aspects. Journal of Dermatological Research. 2016;1(3):51-6. 11. Moslehi A, Hamidi-zad Z. Role of SREBPs in liver diseases: a mini-review. Journal of clinical and translational hepatology. 2018;6(3):332. 12. Tian J, Goldstein JL, Brown MS. Insulin induction of SREBP-1c in rodent liver requires LXRα-C/EBPβ complex. Proceedings of the National Academy of Sciences. 2016;113(29):8182-7. 13. Tarling E, Salter A, Bennett A. Transcriptional regulation of human SREBP-1c (sterol-regulatory-element-binding protein-1c): a key regulator of lipogenesis. Portland Press Ltd.; 2004. 14. Xiao J, So KF, Liong EC, Tipoe GL. Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. Journal of traditional and complementary medicine. 2013;3(2):88-94. 15. Yao H, Qiao Y-J, Zhao Y-L, Tao X-F, Xu L-N, Yin L-H, et al. Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology. 2016;22(30):6890. 16. Tsi D, Das N, Tan B. Effects of aqueous celery (Apium graveolens) extract on lipid parameters of rats fed a high fat diet. Planta medica. 1995;61(01):18-21. 17. Scott Luper N. A review of plants used in the treatment of liver disease: part 1. Alternative Medicine Review. 1998;3(6):410-21. 18. Holmes A, Coppey LJ, Davidson EP, Yorek MA. Rat models of diet-induced obesity and high fat/low dose streptozotocin type 2 diabetes: effect of reversal of high fat diet compared to treatment with enalapril or menhaden oil on glucose utilization and neuropathic endpoints. Journal of diabetes research. 2015;2015. 19. Ferre P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c. Diabetes, obesity and metabolism. 2010;12:83-92. 20. Taher M, Ghannadi A, Karmiyan R. Effects of volatile oil extracts of Anethum graveolens L. and Apium graveolens L. seeds on activity of liver enzymes in rat. The Journal of Qazvin University of Medical Sciences. 2007;11(2):8-12. 21. Singh A, Handa S. Hepatoprotective activity of Apium graveolens and Hygrophila auriculata against paracetamol and thioacetamide intoxication in rats. Journal of ethnopharmacology. 1995;49(3):119-26. 22. Meshkani R, Gorgani-Firuzjaee S. Role of SHIP2 in Oleate Induced De-Novo Lipogenesis. Paramedical Sciences and Military Health. 2015;10(2):26-34. 23. Ebrahimi M, Fathi R, ANSARI PZ, TALEBI GE. Relative Gene Expression of Key Genes Involved in Lipid Metabolism, Following High Fat Diet and Moderate and High Intensity Aerobic Training in Rat’s Liver. 2017. 24. Hashemi Shahraki F, Ghatreh Samani K, Zia Jahromi N, Yaghobi A. Effects of hydroethanolic extract of kelussia odoratissima mozaff. Leaf on total antioxidant capacity and BMP7 gene expression in rat white adipose tissue. Journal of Medicinal Plants. 2018;2(66):113-21. 25. Azarbayjani M, Banaeifar A, Arshadi S. The Effect of Aerobic Training and Adenosine on the Expression of SREBP-1C and A1 Receptor in Hepatic Fat-fed Rats. Iranian Journal of Nutrition Sciences & Food Technology. 2019;14(1):1-9. 26. Jemai R, Drira R, Makni M, Fetoui H, Sakamoto K. Colocynth (Citrullus colocynthis) seed extracts attenuate adipogenesis by down-regulating PPARγ/SREBP-1c and C/EBPα in 3T3-L1 cells. Food Bioscience. 2020;33:100491.
مجله علوم پزشکی پارس